Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Addendum, adenocarcinoma, allele, backbone, Beijing, center, centered, Chengdu, circulating, colorectal, compatible, correlated, CRC, ctDNA, daily, DNA, docetaxel, DPF, ductal, durability, feedback, geopolitical, HHS, Huajian, immunotherapy, longevity, mg, PDAC, pharmacokinetic, randomized, rarer, Shouyao, solid, steady, variant
Removed:
Acute, Colorado, Connecticut, correction, deliver, downturn, East, Ebola, epidemic, essential, half, home, hospital, imposing, indefinite, mandated, Middle, picomolar, postpone, quarantine, raw, recession, reducing, remote, replace, requested, reside, Respiratory, screening, Shield, shipment, sponsoring, spread, substance, sustainability, Syndrome, temporary, travel, unprecedented, Utah, utility, Virginia, widespread, workforce
Valuein 2023 Q1 filing- Value in 2023 Q3 filing
Original filings
Filing view